![Edward Dulac](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Edward Dulac
Financieel Directeur/CFO bij
INTELLIA THERAPEUTICS, INC.
Vermogen: 2 M $ op 31-05-2026
Profiel
Momenteel bekleedt Edward J. Dulac de functie van Chief Financial Officer & Accounting Officer bij Fate Therapeutics, Inc. In het verleden was hij Principal bij CVS, Inc. (Maryland), Vice President-Business Development & Strategy bij Celgene Corp., Principal bij Pfizer (St. Louis), Principal bij Brooks Eckerd Pharmacy, Research Analyst bij Barclays Capital, Inc. en Research Analyst bij Barclays Capital Securities Ltd. Hij behaalde een bachelordiploma aan de Universiteit van Pittsburgh en een MBA aan de Kelley School of Business.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 31-03-2026 | 115.416 ( 0,08% ) | 2 M $ | 31-05-2026 |
Actieve functies van Edward Dulac
| Bedrijven | Functie | Begin |
|---|---|---|
| INTELLIA THERAPEUTICS, INC. | Financieel Directeur/CFO | 22-07-2024 |
Eerdere bekende functies van Edward Dulac
| Bedrijven | Functie | Einde |
|---|---|---|
| FATE THERAPEUTICS, INC. | Financieel Directeur/CFO | 14-06-2024 |
| CELGENE | Corporate Officer/Principal | 01-02-2020 |
Barclays Capital Securities Ltd.
 Barclays Capital Securities Ltd. Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 25-07-2011 |
Pfizer (St. Louis)
 Pfizer (St. Louis) BiotechnologyHealth Technology Provides research services in prescription medicines for humans and animals | Corporate Officer/Principal | 30-11-2007 |
Brooks Eckerd Pharmacy | Corporate Officer/Principal | 30-06-2001 |
Opleiding van Edward Dulac
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
84
Eerstegraads connecties
10
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 10 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
University of Pittsburgh
 University of Pittsburgh Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Barclays Capital, Inc.
 Barclays Capital, Inc. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Barclays Capital Securities Ltd.
Barclays Capital Securities Ltd. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Pfizer (St. Louis)
Pfizer (St. Louis) BiotechnologyHealth Technology Provides research services in prescription medicines for humans and animals | Health Technology |
Fate Therapeutics, Inc.
 Fate Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
Brooks Eckerd Pharmacy | |
CVS, Inc. (Maryland)
 CVS, Inc. (Maryland) Other Consumer ServicesConsumer Services Provides engineering, maintenance, and control programming services for video, audio, and control system | Consumer Services |
Kelley School of Business
 Kelley School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Intellia Therapeutics, Inc.
 Intellia Therapeutics, Inc. BiotechnologyHealth Technology Develops novel and potentially curative therapeutics | Health Technology |
